Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01828060 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population
A Phase 1 study, sponsored by Natural Immune Systems.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT01828060 is a Phase 1 study that has completed, run by Natural Immune Systems. The registered enrollment target is 25 participants.
The verdict
NCT01828060, a Phase 1 study, has completed, sponsored by Natural Immune Systems.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the timing and magnitude of improvements to red blood cell health associated with consumption of Jobelyn™.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Jobelyn™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01828060
The ClinicalTrials.gov registry entry for NCT01828060 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natural Immune Systems, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01828060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01828060 about?
NCT01828060 is a clinical study titled "Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population". The purpose of this study is to evaluate the timing and magnitude of improvements to red blood cell health associated with consumption of Jobelyn™.
What is the current status of trial NCT01828060?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2013-04.
What interventions are being tested in trial NCT01828060?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Jobelyn™ (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01828060?
This trial is sponsored by Natural Immune Systems, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.